Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer
04 avr. 2019 09h15 HE
|
Adhera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, NC, April 04, 2019 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and...
Adhera Therapeutics Provides Third Quarter 2018 Financial Results and Business Update
20 nov. 2018 19h08 HE
|
Adhera Therapeutics, Inc.
Research Triangle Park, NC, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), an emerging specialty pharmaceutical company commercializing therapies that leverage its...